Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus

Clicks: 396
ID: 113875
1998
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
A dose-dependent decrease in infectivity was observed on introduction of eosinophils into suspensions of respiratory syncytial virus group B (RSV-B). This antiviral effect was reversed by ribonuclease inhibitor, suggesting a role for the eosinophil secretory ribonucleases. Recombinant eosinophil-der …
Reference Key
jb1998therecombinant Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Domachowske JB;Dyer KD;Bonville CA;Rosenberg HF;;
Journal The Journal of infectious diseases
Year 1998
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/9607820
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE animals humans pubmed abstract nih national institutes of health national library of medicine amino acid sequence Cells Cultured Molecular Sequence Data cattle sequence homology amino acid dose-response relationship drug eosinophils / physiology* antiviral agents / pharmacology* respiratory syncytial virus human / drug effects* human / genetics j b domachowske h f rosenberg eosinophils / enzymology ribonucleases* pmid:9607820 doi:10.1086/515322 k d dyer eosinophil-derived neurotoxin placental hormones / pharmacology proteins / pharmacology* recombinant fusion proteins / pharmacology ribonuclease pancreatic / antagonists & inhibitors pancreatic / pharmacology* pancreatic / physiology tumor cells

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.